Latest filing published 04 Mar 2026 for Annexon, Inc., €27k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Filings by Jamie Dananberg span 2 companies, the busiest being Unity Biotechnology, Inc. and Annexon, Inc. In total, 28 filings cover trades dated from 7 May 2018 to 2 March 2026.
Every open-market trade on record is a sale: 10 sales worth €86k. The rest of the record consists of 16 share grants. In 2026 alone, the filings show no purchases and 2 sales.
On 4 March 2026 came the latest disclosure, an open-market sale for €27k in Annexon, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
21 of 21 declarations